Should Value Investors Buy Nomura (NMR) Stock?

12.02.25 15:40 Uhr

Werte in diesem Artikel
Aktien

6,21 EUR -0,23 EUR -3,57%

Indizes

PKT PKT

38.963,7 PKT 162,5 PKT 0,42%

7.830,5 PKT -66,5 PKT -0,84%

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.One stock to keep an eye on is Nomura (NMR). NMR is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock holds a P/E ratio of 8.61, while its industry has an average P/E of 14.32. NMR's Forward P/E has been as high as 18.79 and as low as 8.52, with a median of 10.21, all within the past year.Another valuation metric that we should highlight is NMR's P/B ratio of 0.84. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. NMR's current P/B looks attractive when compared to its industry's average P/B of 2.22. NMR's P/B has been as high as 0.86 and as low as 0.64, with a median of 0.75, over the past year.Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. NMR has a P/S ratio of 0.75. This compares to its industry's average P/S of 2.19.Finally, our model also underscores that NMR has a P/CF ratio of 7.85. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. NMR's current P/CF looks attractive when compared to its industry's average P/CF of 16.72. NMR's P/CF has been as high as 16.59 and as low as 6.38, with a median of 9.97, all within the past year.These are just a handful of the figures considered in Nomura's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that NMR is an impressive value stock right now.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nomura Holdings Inc ADR (NMR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Nomura

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nomura

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Nomura Holdings Inc.

Wer­bung

Analysen zu Nomura Holdings Inc.

DatumRatingAnalyst
02.08.2010Nomura outperformCredit Suisse Group
19.01.2010Nomura Holdings chancenreichWirtschaftswoche
09.09.2009Nomura Holdings kaufenAsia Investor
01.07.2009Nomura Holdings kaufenAsia Investor
17.06.2009Nomura Holdings kaufenAsia Investor
DatumRatingAnalyst
02.08.2010Nomura outperformCredit Suisse Group
19.01.2010Nomura Holdings chancenreichWirtschaftswoche
09.09.2009Nomura Holdings kaufenAsia Investor
01.07.2009Nomura Holdings kaufenAsia Investor
17.06.2009Nomura Holdings kaufenAsia Investor
DatumRatingAnalyst
18.02.2005Update Nomura Holdings Inc.: Equal-weightMorgan Stanley
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nomura Holdings Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"